{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023349","form_type":"8-K","ticker":"MAIA","cik":"0001878313","company_name":"MAIA Biotechnology, Inc.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.486696+00:00","generated_at":"2026-05-17T14:00:15.470481+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MAIA Biotechnology granted European patent covering ateganosine-based telomere-targeting anticancer therapy","bullets":["European Patent Office grants patent for ateganosine-based analogues for telomere-targeting anticancer therapy.","Patent titled 'Mercaptopurine Ribonucleoside Analogues for Altering Telomerase Mediated Telomere'; invented by CSO Sergei Gryaznov and SAB member Jerry Shay.","MAIA's global IP portfolio now includes 10 issued patents worldwide, validated in 19 European countries, and 24 pending applications.","Next-generation telomere-targeting agents aim to improve specificity toward cancer cells and increase anticancer activity."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023349","json":"https://secwatch.observer/filing/0001641172-25-023349.json","markdown":"https://secwatch.observer/filing/0001641172-25-023349.md","text":"https://secwatch.observer/filing/0001641172-25-023349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878313/000164117225023349/0001641172-25-023349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878313/000164117225023349/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:00:15.470481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}